1990 May 10, the new factory building of Yunshan Pharmaceutical Factory was completed and moved. 1 14 years 10 14 days, Yunshan Pharmaceutical Factory was officially renamed as Kang Pharmaceutical Company, and the enterprise identification system (CIS) was implemented for the first time in the national pharmaceutical industry and Zhejiang Province, and the Kang brand was officially born.
1990, another important product-Ginkgo biloba extract was developed, which was introduced to China for the first time and exported to the international market.
1992, Ginkgo biloba, the first modern plant medicine in China that meets international standards, was officially approved. Since 1993, Kangbain has set up a prescription drug marketing department in Hangzhou, becoming the earliest pharmaceutical enterprise in China to promote prescription drugs academically, and established the first prescription drug promotion team.
1993 Tianbaoning Ginkgo Capsule, as the first new medicine of Ginkgo biloba extract, obtained the certificate of new medicine from the Ministry of Health.
From 65438 to 0993, Kang became one of the first batch of 36 pilot enterprises of modern enterprise system in the province.
1In May, 1994, Kang's headquarters moved from Lanxi to Hangzhou, and Kang Group was established, becoming the first enterprise in the province to move its headquarters to Hangzhou, which triggered a wave of corporate headquarters moving to the capital in Zhejiang Province.
From 65438 to 0994, Kang acquired Zhejiang Phoenix, which was the first time that a non-listed company acquired a listed company.
1In September 1996, Jinhua Pharmaceutical Factory, the largest state-owned enterprise in Jinhua, was acquired by competition. 438+turned losses into profits in June, 1997, and became the key enterprise of Jinhua city again after 2000. Jinhua Kangenbei has been ranked in the top two of all industrial enterprises at the same level in Jinhua for many years.
In 2000, Dijia Company, the predecessor of Innova, was established, and the new brand "Jin Aokang" was born, which became another well-known brand of Kang Enbei and the first brand in the digestive field of Zhejiang market.
In 2000, Kangbain started its initial public offering of shares, and was officially listed on the Shanghai Stock Exchange on April 6, 2004.
In 2002, Zhejiang Institute of Modern Chinese Medicine and Natural Medicine, the first provincial private drug research institution, was established in Hangzhou.
In 2003, Kang cooperated with Ethypharm, a European multinational pharmaceutical science and technology group, and established Chinese Medicine Center, Zhejiang Branch of National Medical Engineering Center and Zhejiang Chiral Medicine Center in Chengdu Institute of Organic Studies, China Academy of Sciences.
In 2004, Lekang Dabao Capsule was reborn, and Yuanbang Lekang Dabao Capsule successfully landed on the market. After four years of hard work, it has become the first brand of male health care products market in Zhejiang Province.
In August 2004, Kangbain launched the brand strategy of Qianlekang in an all-round way, which triggered the "Hurricane Action on August 28" of Qianlekang and was named as the top ten marketing cases of China medicine in that year.
In 2006, Kang shares were fully circulated, and in September 2007, Jin Huakang was listed indirectly through non-public offering of shares.
In 2008, Kangbain (Lanxi) Modern Plant Medicine Industrial Park, the largest plant medicine industrial base in the province, was completed as a whole and passed GMP certification at one time.
In 2008, it was the first company in Zhejiang traditional Chinese medicine industry to obtain the qualification of enterprise technology center recognized by the state, and in the same period, it was approved by the State Ministry of Human Resources and Social Security to establish a national postdoctoral research center, which is also the first national postdoctoral workstation approved by a Chinese medicine enterprise in this province.
In 2009, Zhejiang Tianbao Medicinal Materials Development Co., Ltd. was established in Lanxi, and the industrial chain of plant medicine plate extended to the cultivation of medicinal plants.
In 2009, we introduced the iron sheet from Kangbain Mountain and established an iron sheet planting base in Yunnan.
On 20/0/0, Jiangxi Longhushan Danxia Health Valley Co., Ltd. and Yunnan Kangenbei Bio-Valley Development Co., Ltd. were established respectively, which officially entered the category of health care and bio-agriculture.
201010, the 20th anniversary celebration of "Kang" brand was successfully held, which is also the starting point for Kang to open a new era of brand management.
20 10, the groundbreaking ceremony of Hangzhou kangenbei biotechnology industry development base officially began.
On August 3rd, 20 12, "Kang Enbei Jin Lan Big Health Industry Belt Double Billion Project" was launched, which marked the core project of Kang Enbei Group's return to Jinhua and the start of the construction of leading enterprises in biomedicine and big health industry in Zhejiang.
In 20 12, Jinhua Kangenbei's products of "Amikacin Sulfate" and "Amikacin Sulfate for Injection" were included in the tuberculosis prevention and control project of the Gates Foundation of the Ministry of Health of China to support WHO's global procurement of drugs for African countries. At present, amikacin sulfate products have passed the official pre-examination of WHO on September 20 12.